MedTrace Logo

The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age

NCT05682261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effect of multiple micronutrient supplements in reducing anemia in women of reproductive age in comparison with iron-folic acid.

The main questions it aims to answer are:

* What is the effect of multiple micronutrient supplements in reducing anemia among women of reproductive age in comparison with iron-folic acid?
* What is the effect of multiple micronutrient supplements in reducing iron deficiency among women of reproductive age in comparison with iron-folic acid?

Participants will

* be given multiple micronutrient supplements, iron folic acid, or placebo twice weekly for 17 weeks
* be asked to respond to the interview
* provide blood, urine, and stool samples

Researchers will compare the control group with the intervention groups to see the effect of multiple micronutrient supplements on iron deficiency and anemia reduction.

Conditions

Interventions

DIETARY_SUPPLEMENT

UNIMMAP-MMS

The study participants in this arm will receive the United Nations International Multiple Micronutrient Antenatal Preparation-Multiple Micronutrient Supplements (UNIMMAP-MMS) containing 15 micronutrients including 30 mg of iron and 400 µg of folic acid.

DIETARY_SUPPLEMENT

IFA

The study participants in this arm will receive iron-folic acid supplements with 30 mg of iron and 400 µg of folic acid.

OTHER

Placebo

The study participants in this arm will receive placebo made of sugar (lactose anhydrous).

Sponsors & Collaborators

  • Oklahoma State University

    collaborator OTHER

  • Addis Ababa University

    collaborator OTHER

  • Ethiopian Public Health Institute

    lead OTHER_GOV

Principal Investigators

  • Masresha Tessema, PhD · Ethiopian Public Health Institute (EPHI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2023-10-17
Completion
2023-10-17

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05682261 on ClinicalTrials.gov